Page 165 - Demo

SECTION I: MOLECULAR GENETIC ENGINEERING AND BIOCHEMICAL TECHNOLOGY 169Funding: This work was performed under the financial support of Vietnam-Czech Republic joint research project (Grant No. N%u0110T/CZ/23/07). Conflicts of Interest: The authors declare no conflict of interest.REFERENCES1. Medzhitov, R. Origin and physiological roles of inflammation. Nature 2008, 454(7203), 428-435.2. Ahmed, A.U. An overview of inflammation: mechanism and consequences. Front Biol 2011, 6(4), 274-281.3. Placha, D.; Jampilek, J. Chronic inflammatory diseases, anti-inflammatory agents and their delivery nanosystems. Pharmaceutics 2021, 13(1), 64.4. Dinarello, C.A. Anti-inflammatory agents: present and future. Cell 2010, 140(6), 935-950.5. Khairullah, A.R.; Solikhah, T.I.; Ansori, A.N.M.; et al. Medicinal importance of Kaempferia galanga L. (Zingiberaceae): A comprehensive review. J Herbmed Pharmacol 2021, 10(3), 281-288.6. Wen, P.; Zong, M.H.; Linhardt, R.J.; Feng, K.; Wu, H. Electrospinning: A novel nano-encapsulation approach for bioactive compounds. Trends Food Sci Technol 2017, 70, 56-68.7. Thomas, M.S.; Pillai, P.K.; Faria, M.; et al. Electrospun polylactic acid-chitosan composite: A bio-based alternative for inorganic composites for advanced application. J Mater Sci Mater Med 2018, 29, 1-12.8. Hu, X.; Liu, S.; Zhou, G.; et al. Electrospinning of polymeric nanofibers for drug delivery applications. J Controlled Release2014, 185, 12-21.